Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
SMARTSCORE: 3.6/5
MatsukiyoCocokara (3088 JP)
Watchlist
113
Analysis
Consumer Staples
•
Japan
MatsukiyoCocokara & Co. operates drug store chains. The Company retails medicines, cosmetics, health foods, beauty care products, and other products. MatsukiyoCocokara & also operates supermarkets and home centers.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
30 Aug 2021 13:20
The Polarising Pandemic in Japanese Retail
A complete review of the Japanese retail sector in the last 18 months, format by format, category by category, providing key trends and winners &...
Michael Causton
Follow
394 Views
Share
bullish
•
Quantitative Analysis
•
31 Jul 2021 00:00
Asia Shorts: Kuaishou, EDU, Fuyao, Galaxy, KDDI, Sharp, HMC, HMM, SK Tel, Naver, Novatek, Yageo
The Insight looks at large short interest movements across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...
Brian Freitas
Follow
294 Views
Share
bearish
•
MatsukiyoCocokara
•
21 Jul 2021 03:37
Japan's Governance: Founder Family Ownership / Case of Drugstore Industry
I would like to discuss the founder's ownership ratio and the future of performance and governance in the case of 10 major drugstore companies that...
Metrical Inc
Follow
209 Views
Share
bullish
•
MatsukiyoCocokara
•
04 May 2021 19:45
Japan Drugstores: Growing Leadership in Food, Household, Cosmetics – and the Odd Medicine Too
The Japanese drugstore sector has seen a big merger but there will be more as the sector not only consolidates down to a few leaders but also...
Michael Causton
Follow
394 Views
Share
bullish
•
Intouch Holdings
•
30 Apr 2021 00:00
(Mostly) Asia M&A: April 2021 Roundup
The average premium for the new deals announced (or first discussed) in April was ~13%, with a year-to-date average of ~30% (66 deals).
David Blennerhassett
Follow
443 Views
Share
First
Previous
7
8
9
10
11
12
13
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.55.2
x